AMGN · NASDAQ · Drug Manufacturers - General

Amgen

Develops and manufactures medicines and biosimilars across general medicine, rare disease, inflammation, and oncology.

$430.27
After-hours close−2.11 (−0.49%)
At close$432.38(−1.05%)

Breakdown13F · Form 4

Institutions 140.68%Insiders 0.19%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 539.71M · Float 538.22M · 99.7% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.49.36M9.15%13FAug 7, 2026
Vanguard Capital Management LLC35.25M6.53%13FAug 13, 2026
State Street Corp30.56M5.66%13FAug 7, 2026
Capital World Investors29.08M5.39%13FAug 12, 2026
Invesco Ltd.16.32M3.02%13FAug 14, 2026

Institutions13F, as of Jun 30, 2026

3,233 holders · 759.26M shares · 183 new positions · 1,445 increased · 1,231 reduced · 175 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.49.36M9.15%+2.26MAug 7, 2026
Vanguard Capital Management LLC35.25M6.53%+235.9KAug 13, 2026
State Street Corp30.56M5.66%+12.0KAug 7, 2026
Capital World Investors29.08M5.39%−213.0KAug 12, 2026
Invesco Ltd.16.32M3.02%+5.01MAug 14, 2026
Geode Capital Management, LLC15.70M2.91%+265.5KAug 12, 2026
Sixth Street Partners Management Company, L.P.15.03M2.79%+15.03MnewAug 14, 2026
Charles Schwab Investment Management Inc15.03M2.79%+2.26MAug 14, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
BlackRock, Inc.7.60%40.83M13GApr 17, 2025
Vanguard Capital Management7.51%40.51M13GApr 29, 2026
Capital World Investors5.50%29.60M13GMay 14, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Robert A. Bradwaydirector, officer: Chairman, CEO and President595.2K0.11%May 11, 2026
Esteban Santosofficer: EVP, Operations82.8K0.02%May 11, 2026
Murdo Gordonofficer: EVP, Global Commercial Ops51.2K0.01%May 11, 2026
Peter H. Griffithofficer: EVP & CFO50.2K0.01%May 11, 2026
David M. Reeseofficer: EVP & Chief Technology Officer42.3K0.01%May 11, 2026
Jonathan P. Grahamofficer: EVP & Gen. Counsel & Sec.39.7K0.01%May 11, 2026
James E. Bradnerofficer: EVP, Research and Development30.0K0.01%May 11, 2026
Robert Eckertdirector26.3K0.00%May 21, 2026
Tyler Jacksdirector18.3K0.00%May 21, 2026
Ellen Jamison Kullmandirector14.5K0.00%May 21, 2026

1 ten-percent owner holds 1.12M shares by Form 4, outside the officers-and-directors figure above · 42 people have not refiled in the last 18 months (3.42M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 13, 2026
Rachna Khoslaofficer: SVP, Business Development
Sale1,252$416.436,404
Aug 11, 2026
Rachna Khoslaofficer: SVP, Business Development
Sale2,000$412.576,404
Aug 6, 2026
Nancy A. Grygielofficer: SVP & CCO
Sale1,000$402.167,340
Aug 6, 2026
Derek Millerofficer: SVP, Human Resources
Sale1,821$402.5412,462
May 4, 2026
Nancy A. Grygielofficer: SVP & CCO
Sale1,237$323.737,009
Feb 26, 2026
Esteban Santosofficer: EVP, Operations
Sale24,291$379.1276,618
Feb 19, 2026
Matthew C. Buschofficer: VP, Finance & CAO
Sale1,000$375.793,423
Nov 20, 2025
Nancy A. Grygielofficer: SVP & CCO
Sale1,639$337.267,225
Nov 12, 2025
Murdo Gordonofficer: EVP, Global Commercial Ops
Sale6,879$336.8341,923
Nov 12, 2025
Rachna Khoslaofficer: SVP, Business Development
Sale890$336.247,082

CongressHouse and Senate disclosures

MemberTypeAmountOwnerTradedDisclosed
Sen. Tommy Tuberville · ALSale$15,001 – $50,000JointApr 15, 2025Aug 5, 2026
Rep. Ro Khanna · CA17Purchase$1,001 – $15,000Jun 2, 2026Jul 8, 2026
Rep. David Taylor · OH02Purchase$1,001 – $15,000Jun 5, 2026Jun 15, 2026
Rep. Maria Elvira Salazar · FL27Sale$15,001 – $50,000Apr 17, 2026May 11, 2026
Sen. Mark Warner · VASale$1,001 – $15,000SelfApr 7, 2026May 1, 2026